Biomerica, Inc. (NASDAQ:BMRA)

Biomerica, Inc. develops, manufactures, and markets medical diagnostic product for the early detection and monitoring of chronic diseases and medical conditions. The company’s diagnostic test kits are used to analyze blood or urine from patients in the diagnosis of various diseases and other medical complications, or to measure the level of specific hormones, antibodies, antigens, or other substances, which might exist in the human body in extremely small concentrations. Its clinical laboratory diagnostic products include tests for bone and anemia conditions, gastrointestinal diseases, food intolerance, and diabetes. The company provides its products primarily to distributors, hospital and clinical laboratories, medical research institutions, medical schools, pharmaceutical companies, chain drugstores, wholesalers, and physicians’ offices worldwide. Biomerica, Inc. was founded in 1971 and is headquartered in Irvine, California.